InvestSMART

Medical Developments International Limited (ASX: MVP) - Announcements

Current share price for MVP : $0.455 0.005 (1.09%)+

ASX company news and announcements for Medical Developments International Limited (MVP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Medical Developments International Limited (MVP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Medical Developments International Limited (MVP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Medical Developments International Limited (MVP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$51 MVP announces leadership change 5 Mar 2020 9:12AM $8.510 $0.455 fallen by 94.65%
$51 Dividend/Distribution - MVP 19 Feb 2020 12:28PM $10.470 $0.455 fallen by 95.65%
$51 FY20 HY Report and Accounts 19 Feb 2020 8:38AM $10.840 $0.455 fallen by 95.80%
$51 Appendix 3B 29 Jan 2020 8:24AM $10.330 $0.455 fallen by 95.60%
$51 Appendix 3B 2 Jan 2020 11:53AM $8.900 $0.455 fallen by 94.89%
$51 Becoming a substantial holder 10 Dec 2019 4:58PM $7.190 $0.455 fallen by 93.67%
$51 Penthrox Marketing Authorisation Application in Russia 6 Dec 2019 11:06AM $7.060 $0.455 fallen by 93.56%
$51 Penthrox IND approved in China 21 Nov 2019 8:33AM $6.010 $0.455 fallen by 92.43%
$51 Results of Meeting 30 Oct 2019 2:49PM $5.885 $0.455 fallen by 92.27%
$51 CEO Roadshow Presentation 30 Oct 2019 2:36PM $5.880 $0.455 fallen by 92.26%
$51 Chairman's Address to Shareholders 30 Oct 2019 10:41AM $5.860 $0.455 fallen by 92.24%
$51 MVP signs new Manufacturing Development Project with CSIRO 29 Oct 2019 8:06AM $5.730 $0.455 fallen by 92.06%
$51 Penthrox approved in EUSEM guidelines 24 Oct 2019 9:57AM $5.650 $0.455 fallen by 91.95%
$51 Ceasing to be a substantial holder 23 Oct 2019 11:41AM $5.790 $0.455 fallen by 92.14%
$51 Change in substantial holding 23 Oct 2019 11:37AM $5.830 $0.455 fallen by 92.20%
$51 Penthrox is launched in Italy 23 Oct 2019 9:11AM $5.790 $0.455 fallen by 92.14%
$51 Positive study results for Penthrox 22 Oct 2019 8:19AM $5.170 $0.455 fallen by 91.20%
$51 Change of Director's Interest Notices 4 Oct 2019 11:44AM $4.990 $0.455 fallen by 90.88%
$51 Appendix 3B 4 Oct 2019 11:41AM $4.990 $0.455 fallen by 90.88%
$51 Appendix 3B 30 Sep 2019 11:23AM $4.970 $0.455 fallen by 90.85%
$51 Annual Report to Shareholders 25 Sep 2019 4:55PM $4.880 $0.455 fallen by 90.68%
$51 Notice of AGM/Proxy Form 25 Sep 2019 4:49PM $4.880 $0.455 fallen by 90.68%
$51 MVP Roadshow Presentation 5 Sep 2019 2:55PM $4.760 $0.455 fallen by 90.44%
$51 Update - Dividend/Distribution - MVP 4 Sep 2019 4:16PM $4.780 $0.455 fallen by 90.48%
$51 Corporate Governance Statement 21 Aug 2019 12:10PM $4.940 $0.455 fallen by 90.79%

301 - 325 of 615 results

Page 13 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.